Neuro42 appoints lead investor GVK’s Krishna Bhupal to its board of directors

Hyderabad: Neuro42, Inc, a medical technology company leading the next evolution of MRI and robotics, on Wednesday announced it has appointed its lead investor, Krishna Bhupal, to its Board of Directors.
Bhupal is an accomplished entrepreneur and investor who has demonstrated a track record of delivering significant shareholder value, the company said in a release.
His current involvements are in the following key industries: energy, TAJGVK hospitality, health and real estate. His current investments are focused on the deep tech space, including MedTech, and includes over 12 companies at various stages of maturity.
“We are excited to have Krishna Bhupal join the neuro42 team. Krishna’s vast experience as a deep technology investor and being a business leader will enable us navigate the ever-changing global landscape. As a team we look forward to his leadershipp as we drive awareness and market penetration as we scale our differentiated technology,” said Abhita Batra, Founder and Chief Strategy Officer of neuro42.
“We are executing to plan and having a successful entrepreneur like Krishna on our board gives us the advantage of an advisor and investor who is supportive of our mission to advance MRI from screening to robotic intervention,”Batra added.
Krishna said, “I look forward to the Company’s next phase of growth and for it to continue to be a pioneer in the imaging and robotics space in America and move into the scale up phase.”